The global plethysmograph market is prognosticated to benefit from applications in a number of medical fields such as pediatric healthcare technology, pregnancy, and sexology. Recently, the Christchurch hospital of the Canterbury District Health Board purchased New Zealand’s alleged leading pediatric respiratory facility, Body Plethysmograph, after receiving a hefty donation from Countdown Kids. The plethysmograph could be the first of its kind in the whole of New Zealand. Charitable contributions made to local healthcare organizations owing to their financial issues could showcase some influence on the growth of the overall market.
Different types of plethysmograph could be engaged for different purposes in the medical sector. For instance, plethysmograph is anticipated to be used in studies that determine whether diets followed during pregnancy could influence adiposity and fat mass in newborns. A prospective-cohort study conducted by HealthStart in the U.S. measured adiposity, fat-free mass, and fat mass in newborns with the help of an air displacement plethysmograph, the PEA POD device. This device is designed to calculate body composition in infants using densitometry.
Download Brochure Copy of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26678
In sexology, penile plethysmograph could be picked as a choice tool for phallometry, which is a process of measuring erections over a period of time. Phallometry could take several forms. Of all the prominent ones, one type could directly measure the volume of the penis while another the girth. Penile plethysmograph is also predicted to have strong political and legal implications. For instance, the device could be specifically used for judging the probability of reoffending in sex offenders. The Czech government is known for supposedly inventing phallometry to weed out draft-dodgers. In academia, phallometry is projected to find application in quantitatively evaluating differences on the extensive band of human sexual orientation.
Plethysmography is a non-invasive process to measure the changes in volume in a particular organ or the whole body, by observing either the blood contained in it or the fluctuations occurring in the air. The process involves blood pressure cuffs or other types of sensors which are connected to a machine called as plethysmograph. The doctor may recommend plethysmography if a person exhibits signs of respiratory problems or a blood clot in the limbs. The whole body plethysmograph consists of an airtight chamber, in which a patient is seated. The thoracic movement of a person while breathing are transferred into the volume, which are measured & evaluated. All plethysmograph work on the same principle, which are considered to be clinically more reliable than other volume detection techniques.
Ask for Discount on Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26678
Its low cost and the fact that it is a less invasive procedure are major factors predicted to drive the plethysmograph market during the forecast period. However, the availability of alternate methods for plethysmography such as gas dilution tests and spirometry which are also less expensive is projected to restrain the market during the forecast period.
Globally, the plethysmograph market is segmented based on type into the lung, body, limb, and others divisions. Lung plethysmographs accounted for a major market share in terms of revenue in 2016. The rising prevalence of lung disorders owing to the consumption of tobacco & alcohol and sedentary lifestyles are anticipated to drive the plethysmograph market during the forecast period. However, limb and body plethysmographs are expected to witness high CAGRs during the forecast period which is attributed to the precision and accuracy offered by the two methods and the rising geriatric population. The low capability of substitute methods such as spirometers to provide absolute lung volume is likely to be a major driver of this segment during the forecast period.
In terms of application, the global plethysmograph market is classified into the adult and baby categories. Adults captured a major market share in terms of revenue owing to the rising number of cardiovascular disorders caused by sedentary lifestyles and the growing awareness about technologically advanced diagnostic techniques. However, the babies segment is estimated to observe a high CAGR owing to technological advancements in the fluctuating volume detection techniques and the increasing prevalence of lung & cardiovascular disorders in infants.
On the basis of end-user, the global plethysmograph market is divided into the following groups: hospitals, ambulatory surgical centers, clinics, and others. Hospitals generated extensive revenue in 2016 owing to their positive reimbursement policies, improved infrastructure, and other medicare facilities. Clinics and ambulatory surgical centers are estimated to exhibit rapid CAGRs during the forecast period on account of the rising prevalence of lung disorders and the shifting patient preference toward preventive health care. However, rising per capita expenditures are a major factor predicted to propel the segment during the forecast period.
Geographically, the global plethysmograph market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a prominent market share in 2016 due to the rising adoption of technologically advanced diagnostic techniques in the country. Asia Pacific is likely to record a high CAGR during the forecast period due to government funding toward the prevention and control of vital diseases in India & China and rising awareness about plethysmography techniques. Rising demand for precise & accurate diagnostic tools is projected to drive the market for plethysmographs in North America by 2025.
Prominent players in the plethysmograph market globally include D. E. Hokanson, Inc., Becton, Dickinson and Company (Carefusion), COSMED, MGC Diagnostics Corporation, MEC (Medical Electronic Construction), Geratherm, and Ganshorn.